Back to User profile » Dr Julio C Chavez

Papers published by Dr Julio C Chavez:

Review

Axicabtagene Ciloleucel in the Management of Follicular Lymphoma: Current Perspectives on Clinical Utility, Patient Selection and Reported Outcomes

Mohty R, Kharfan-Dabaja MA, Chavez JC

Cancer Management and Research 2023, 15:367-375

Published Date: 19 April 2023

Review

Assessing and Management of Neurotoxicity After CAR-T Therapy in Diffuse Large B-Cell Lymphoma

Castaneda-Puglianini O, Chavez JC

Journal of Blood Medicine 2021, 12:775-783

Published Date: 24 August 2021

Review

Cytokine Release Syndrome: Current Perspectives

Murthy H, Iqbal M, Chavez JC, Kharfan-Dabaja MA

ImmunoTargets and Therapy 2019, 8:43-52

Published Date: 29 October 2019

Review

Axicabtagene ciloleucel (KTE-C19), an anti-CD19 CAR T therapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin’s lymphoma

Jain MD, Bachmeier CA, Phuoc VH, Chavez JC

Therapeutics and Clinical Risk Management 2018, 14:1007-1017

Published Date: 31 May 2018

Review

Ibrutinib: an evidence-based review of its potential in the treatment of advanced chronic lymphocytic leukemia

Chavez JC, Sahakian E, Pinilla-Ibarz J

Core Evidence 2013, 8:37-45

Published Date: 16 May 2013